|
Originally published In Press as doi:10.1074/jbc.M004759200 on September 14, 2000
J. Biol. Chem., Vol. 275, Issue 52, 41396-41404, December 29, 2000
Up-regulation of Na,K-ATPase 1 Transcription
by Hyperoxia Is Mediated by SP1/SP3 Binding*
Christine H.
Wendt §,
Greg
Gick¶,
Renuka
Sharma ,
Yong
Zhuang¶,
Wenlian
Deng , and
David H.
Ingbar
From the University of Minnesota, Department of Medicine,
Minneapolis, Minnesota 55455 and the ¶ Department of
Biochemistry, State University of New York, Health Science Center,
Brooklyn, New York 11203-2012
Received for publication, June 1, 2000, and in revised form, August 25, 2000
 |
ABSTRACT |
The sodium pump, Na,K-ATPase, is an important
protein for maintaining intracellular ion concentration, cellular
volume, and ion transport and is regulated both transcriptionally and
post-transcriptionally. We previously demonstrated that hyperoxia
increased Na,K-ATPase 1 gene expression in Madin-Darby
canine kidney (MDCK) cells. In this study, we identify a DNA element
necessary for up-regulation of the Na,K-ATPase 1
transcription by hyperoxia and evaluate the nuclear proteins
responsible for this up-regulation. Transient transfection experiments
in MDCK cells using sequential 5'-deletions of the rat Na,K-ATPase
1 promoter-luciferase fusion gene demonstrated promoter
activation by hyperoxia between 102 and +151. The hyperoxia response
was localized to a 7-base pair region between 62 and 55, which
contained a GC-rich region consistent with a consensus sequence for the
SP1 family, that was sufficient for up-regulation by hyperoxia. This GC
element exhibited both basal and hyperoxia-induced promoter activity
and bound both transcription factors SP1 and SP3 in electrophoretic
mobility shift assays. In addition, electrophoretic mobility
shift assays demonstrated increased binding of SP1/SP3 in cells exposed
to hyperoxia while mutation of this element eliminated protein binding.
Other GC sites within the proximal promoter also demonstrated
up-regulation of transcription by hyperoxia, however, the site at 55
had higher affinity for SP proteins.
 |
INTRODUCTION |
The Na,K-ATPase is a ubiquitous protein that plays an important
role in maintaining cellular homeostasis. The Na,K-ATPase maintains
homeostasis by regulating cellular volume, transepithelial ion
transport, action potential propagation in nerve and muscle cells, and
the sodium-coupled uptake of metabolic substrates such as glucose and
amino acids (1, 2). The Na,K-ATPase is a transmembrane, heterodimer
protein consisting of an and subunit. The subunit contains
the catalytic site responsible for ion translocation, whereas it is
thought that the subunit is responsible for plasma membrane
targeting (3). In lung epithelial cells, evidence supports that the
1 subunit is the rate-limiting unit for functional pumps
(4, 5). Several isoforms exist for each subunit, whereas the
1 and 1 subunits predominate in
epithelial cells. The Na,K-ATPase is regulated both transcriptionally,
by glucocorticoids, thyroid hormone, and hyperoxia, and
post-transcriptionally (5-10).
We, and others, have previously demonstrated that hyperoxia can
up-regulate Na,K-ATPase gene expression in lung epithelial cells (5,
10-12). The amount of up-regulation ranges between 2- and 6-fold and
varies according to the duration of exposure and oxygen concentration
(5, 10-12). In addition, these relatively small changes in gene
expression result in physiological responses with concomitant increases
in protein levels and activity, which are also dependent on the dose
and duration of oxygen exposure (10, 11). The up-regulation of the
Na,K-ATPase by hyperoxia in the lung has physiological significance,
because the lung is exposed to oxidant stress continuously, due to high
oxygen tension. Oxidant stress can be exacerbated during lung injury
and the therapeutic need for high oxygen delivery. We sought a model
cell line to determine the molecular mechanism by which hyperoxia
increased Na,K-ATPase gene expression, and screening of several
epithelial cell lines revealed
MDCK1 cells to be an
excellent model.
MDCK cells are a canine kidney epithelial cell line that is abundant in
Na,K-ATPase. In culture, these cells form domes when exposed to
hyperoxia, presumably due to increased ion transport (13). Although the
kidney is not exposed to high oxygen tension, it is exposed to oxidant
stress during ischemia and injury.
The role of oxidants and oxygen tension on gene regulation has been
recognized in several systems. Several transcription factors have been
identified that up-regulate eukaryotic gene expression in the presence
of oxidizing conditions, such as the anti-oxidant responsive element,
AP1, and NF B (14-16). The mechanism by which oxidants
up-regulate transcription has been most clearly defined for NF B,
however, for many genes the mechanism remains undefined. We previously
demonstrated that hyperoxia up-regulated gene expression of the
Na,K-ATPase 1 and 1 subunits in MDCK
cells (5, 9). In this cell system, hyperoxia increased the Na,K-ATPase
1 subunit transcription via a 61-bp region on the
1 subunit promoter. Although the Na,K-ATPase
1 promoter contains putative AP1 and NF B sites, these
sites were not located in the 61-bp region necessary for hyperoxia
induction. Rather, this sequence contained a core GC element consistent
with an SP family consensus site.
In this study, we demonstrated that an SP site is required for the
up-regulation of the Na,K-ATPase 1 subunit transcription by hyperoxia in MDCK cells. Deletion of the GC element resulted in loss
of both basal and hyperoxia-activated transcription. MDCK cells treated
with hyperoxia demonstrated increased binding of SP1/SP3 in
electrophoretic mobility shift assays (EMSA), which was eliminated with
mutation of the GC consensus sequence. This represents a novel function
for SP family transcription factors.
 |
MATERIALS AND METHODS |
Cell Culture--
Three cell lines were tested to determine
whether hyperoxia increased gene expression of the Na,K-ATPase. These
cell lines included two lung epithelial cell lines (MP48, gift
from G. Hunninghake; A549, ATCC) and one kidney epithelial cell line
(Madin-Darby canine kidney (MDCK), low resistance, ATCC CCL 34). Only
the MDCK cells had an increase in Na,K-ATPase gene expression by
hyperoxia (data not shown) and were used for subsequent analysis. Cells
were cultured on plastic tissue culture dishes and incubated in
Eagle's minimum essential medium with Earle's salts (Life
Technologies, Inc.). The media was supplemented with 10% fetal bovine
serum (FBS; Life Technologies, Inc.) and 100 units/ml penicillin, 100 µg/ml streptomycin, and 2.5 µg/ml amphotericin B (Life
Technologies, Inc.). Cells were incubated in 5% CO2/95%
air (normoxia) at 37 °C. Cells treated with hyperoxia were placed in
a humidified, sealed chamber (Billups) that was flushed with 5%
CO2/95% O2 at 5 liters/min for 10 min each day
of incubation under normobaric conditions. Cells treated with 0.2 mM diamide were placed in an incubator under
normoxic, normobaric conditions. Cells were subconfluent at the start
of the experiments and became confluent by 48 h of incubation,
either in normoxic or hyperoxic conditions.
Nuclear Run-on Assays--
Plasmids containing: pGEM empty
plasmid (control), and Na,K-ATPase 1 subunit cDNA
(gift from E. Benz, Johns Hopkins) were placed into wells of a slot
blot (10 µg/slot) on nitrocellulose filters and vacuum-dried. The
Na,K-ATPase 1 subunit cDNA was contained in the pGEM
plasmid, therefore, pGEM was chosen as a negative control to measure
nonspecific binding. Nuclei were isolated from MDCK cells (5 × 106) by cell lysis using standard techniques (8). Nuclei
were incubated with nucleotides and 0.5 mCi of [32P]UTP
for 30 min at 37 °C before terminating the reaction with DNase I and
extracting and precipitating the RNA. The RNA was resuspended in
prehydridization solution, and 1 million counts of each sample was
hybridized to the slot blots in the smallest possible volume for
48 h and then washed with 2× SSC. The nitrocellulose filters were
then autoradiographed. The RNA integrated optical density was
determined using Densitometry Image software.
Plasmid Construction--
The Na,K-ATPase 1
promoter-reporter constructs consisted of the 5'-promoter region plus
151 bp of the first exon linked to a promoterless firefly luciferase
expression vector (pXP1-luc), as previously reported (9, 17). The
deletion constructs designated 1-102,
1-84, 1-62, and 1-55
contained 102, 84, 62, and 55 bp, respectively, upstream from the
transcription start site to +151 base pairs (Fig.
1). The 1-102 construct
was created by exonuclease III digestion of a 1-817
construct as described previously (9, 17). Luciferase constructs that
contained the 1-84, 1-62, and
1-55 promoter sequences were synthesized using
polymerase chain reaction (PCR) amplification. Oligonucleotides from
84 to +151, 62 to +151, and 55 to +151 were generated by PCR
using 1-102 as a template. The reactions to synthesize
the 84 to +151 and 62 to +151 oligonucleotides were performed in a
total volume of 100 µl containing 1 µg of template, 0.2 mM dNTPs, 2 µM of each primer (5'-primers,
GCGGATCCGATTGGCCTGCGGTGCGGATCCTAGGCGGAGCTAC; 3'-primer,
GCAAGCTTGCATGCAGG), 2.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1% Triton
X-100, and 2.5 units of Taq polymerase (Promega). The run
included 25 cycles, and each cycle consisted of: denaturation for
15 s (94 °C), annealing for 15 s (70 °C), and
elongation for 1 min and 15 s (72 °C). The PCR fragments were digested with BamHI and ligated into the BamHI
site of the luciferase vector pXP1. The PCR reaction to synthesize the
55 to +151 oligonucleotide was performed in a total volume of 50 µl
containing 30 ng of template, 0.1 mM dNTPs, 0.1 mM of each primer (5'-primers,
AAAGAATCCGAGCTACGGATGGTGGAGGC; 3'-primer, CTTGAATCCCCTGCTGCTTCAAG), 2 mM MgCl2, 10 mM
(NH4) 2SO4, 10 mM KCl,
20 mM Tris-HCl (pH 8.8), 0.1% Triton X-100, and 2.5 units
of Pfu polymerase (ProStratagene). The run included 28 cycles, and each
cycle included: denaturation for 1 min 30 s (96 °C), annealing
for 40 s (60 °C), and elongation for 1 min and 30 s (68 °C). The PCR fragment was digested with BamHI and
ligated into the BamHI site of the luciferase vector pXP1.
Each clone was sequenced to confirm the appropriate DNA sequence.
Transfection experiments with the empty vector did not demonstrate
luciferase activity above background, either in normoxia or hyperoxia.
For a control, cells were transfected with the 1-41
construct, which contained 41 bp upstream from the transcription start
site to +151 base pairs of the first exon, to test whether the vector or the 3'-region was responding to hyperoxia. This construct
demonstrated less than 5% luciferase activity compared with the
1-102 construct, similar to the empty vector (data not
shown) and did not demonstrate increased activity in hyperoxia.

View larger version (5K):
[in this window]
[in a new window]
|
Fig. 1.
Na,K-ATPase promoter-reporter
constructs. The constructs consisted of the 5'-promoter plus 151 bp of the first exon linked in the promoterless luciferase expression
vector (pXP1-Luc).
|
|
To confirm that the region from 59 to 55 was sufficient for
hyperoxic induction independent of the Na,K-ATPase endogenous promoter,
an oligonucleotide spanning this region was subcloned into a vector
containing a minimal promoter of the mouse mammary tumor virus
(MMTV-ATCC 37582) for transfection experiments. A 38-bp oligonucleotide
was synthesized that spanned from 82 to 44
(5'-ATTGGCCTGCGGTGCCGCCCGGTAGGCGGAGCTACGGATG-3'; University of
Minnesota Molecular Laboratory) and was subcloned into a luciferase vector containing a minimal promoter of the mouse mammary tumor virus.
In addition, a 38-bp oligonucleotide was synthesized that spanned from
82 to 44, which contained a mutation of the GC site at 68
(5'-ATTGGCCTGCGGTGCTCTCCGGTAGGCGGAGCTACGGATG-3' University of Minnesota Molecular Laboratory) and was subcloned into the MMTV-luciferase plasmid. The minimal promoter consisted of 109 bp of
the 5'-proximal promoter of the MMTV linked to the luciferase gene. The
oligonucleotides were subcloned into
HindIII/SacI-digested MMTV-luc plasmid. Plasmids
were transformed in Escherichia coli and isolated using the
Qiagen maxi-prep and designated MMTV-82/44WT and MMTV-82/44SM.
To generate a construct with point mutations, we utilized a PCR-based
method (Stratagene) using the double-stranded, supercoiled DNA vector,
1-102, which was annealed to two synthetic complementary oligonucleotides ( 84 to 42) containing the desired mutation of the
GC sites at 68 and 59
(5'-CGATTGGCCTGCGGTGCTCTCCGGTAGAGAGAGCTACGGATGGT-3'). The extension and incorporation of the mutant primers were accomplished by PCR. The PCR-generated mutant plasmid was treated with
DpnI, which specifically digested the hemi-methylated
wild type parental DNA plasmid and eliminated the non-mutant template
from the PCR reaction. The plasmid containing the PCR-generated
mutation was transformed and isolated as described above. The plasmid
was sequenced to confirm the presence of the desired mutations and was
designated 1-102DM.
DNA Transfection Experiments--
MDCK cells were plated at a
density of 8 × 106 cells/35-mm plate in media with
10% FBS. On the second day of culture, each well was transfected with
10 µl of Superfect (Qiagen) and 2 µg of the 1
promoter-reporter construct. Lipofection was carried out using the
manufacturer's recommendation for a total of 4 h in serum-free
and antibiotic-free media. After lipofection, the cells were incubated
for 48 h in media plus 10% FBS in normoxia or hyperoxia. Cells
were lysed and assayed for luciferase activity (Luciferase Assay
System, Promega) in a luminometer (LB 9501, Berthold), and protein
concentration was measured by the bicinchoninic acid system of Pierce.
Luciferase activity normalized to either co-transfection with a
CMV-LacZ plasmid or protein concentration was identical, therefore, all
subsequent transfections were normalized to protein concentration as
described previously (8). MDCK cells grew to confluency in both
normoxic and hyperoxic conditions, however, overall cell number and
total protein were less in the hyperoxia experiments. All normalized
promoter activity was reported as a percentage activity over control (normoxia).
Electrophoretic Mobility Shift Assays (EMSA)--
To prepare
nuclear extracts, cells were suspended in hypotonic solution (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.2 mM PMSF, and 0.5 mM
dithiothreitol (DTT)) to lyse the cells and homogenized, and the nuclei
were collected by centrifugation. High salt buffer was added slowly to
release soluble proteins from the nuclei. The nuclei were pelleted by
centrifugation, and the supernatant was dialyzed into a moderate salt
solution (20 mM HEPES, 20% glycerol, 100 mM
KCl, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT; a reducing agent), and any precipitated protein was
removed by centrifugation. Approximately 2-5 × 108
cells were needed to obtain 100-150 µg of nuclear extract.
Whole cell extracts (WCE) were obtained from MDCK cells incubated in
media plus 10% FBS and incubated for 24 h in normoxia, hyperoxia,
or 0.2 mM diamide. To prepare whole cell extracts, cells
were suspended and washed in phosphate-buffered saline, followed by
buffer A (10 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.2 mM PMSF, and
0.05 mM DTT). Next, cells were lysed in buffer B (0.1%
Nonidet P-40, 20 mM HEPES, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM PMSF, 0.05 mM DTT) followed by centrifugation and collection of the supernatant. The
supernatant was diluted to 100 µl per 107 cells with
modified buffer C (10 mM KCl, 20 mM HEPES, pH
7.9, 20% glycerol, 50 mM KCl, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT). Protein concentration was
determined by the bicinchoninic acid system.
The double-stranded oligonucleotide probes were generated by the
University of Minnesota Molecular Laboratory and were gel-purified. The
probes were as follows: 82/ 44
(5'-ATTGGCCTGCGGTGCCGCCCGGTAGGCGGAGCTACGGATG-3'); 122/ 84
(5'-CCGCCCCTTCGGGCTCAGGCCCGCCTTCTCGGCACCGGC-3'); 84/ 42DM (5'-CGATTGGCCTGCGGTGCTCTCCGGTAGAGAGAGCTACGGATGGT-3');
84/ 42SM (5'-ATTGGCCTGCGGTGCTCTCCGGTAGGCGGAGCTACGGATG-3').
The oligonucleotides were end-labeled with a random primer kit
(Promega) using [32P]CTP and Klenow fragment. The probe
was electrophoresed, eluted, and resuspended in TE buffer. The binding
reaction included 1 × 104 cpm of DNA probe (0.2-0.7
ng), bulk carrier DNA, and 6.5-8.0 µg of extract in 24-36 µl of
10× binding buffer (100 mM TrisCl (pH 7.5), 500 mM NaCl, 5 mM DTT, 50 mM
MgCl2, 50% glycerol) incubated for 20 min at room
temperature. The reaction mixture was placed in a 4% polyacrylamide
gel and electrophoresed at 4 °C, blotted, and autoradiographed using
standard methods (8). Competition experiments consisted of incubating
the probe and extract with excess cold competitor, double-stranded
oligonucleotides prior to electrophoresis. The SP1 and AP1
double-stranded oligonucleotides (Promega) used in competition assays
contained 21 and 22 bp, respectively. Each oligonucleotide contained
the core consensus sequence for either SP1 or AP1. Other
oligonucleotides used in competition assays included: 86/ 62
(5'-GGCGATTGGCCTGCGGTGCCG-3'); and 66/ 44 (5'-GCCGGTAGGCGGAGCTACGGATG-3'). Supershift assays involved
incubation of probe and extract with 2 µl of antibodies (Santa Cruz
Biotechnologies) to the SP1 and SP3 transcription factors prior to
electrophoresis. The SP antibodies were polyclonal, rabbit IgG
antibodies that were not cross-reactive with other SP family members of
different species, as reported by the manufacturer.
Western Analysis--
Whole cell extracts (50 µg), as
described above, were separated by 8% SDS-polyacrylamide gel
electrophoresis and then transferred onto Hybond-nitrocellulose
membrane. The blot was blocked overnight with 10 ml of TBST
(Tris-buffered saline, 0.05% Tween 20, 0.02% NaN3) with
6% powdered milk. This was followed by incubation with the goat
polyclonal SP1 antibody (final dilution 1/100; Santa Cruz) at room
temperature for 1 h. After incubation, the blot was washed three
times with TBST and then incubated with horseradish peroxidase-conjugated secondary anti-goat antibody (final dilution 1/2000) for 1 h. After washing with TBST, bands were visualized using the enhanced chemiluminescence method (Amersham Pharmacia Biotech). Probing for SP3 and actin was performed separately, after the
blot was stripped with buffer (62.5 mM Tris, pH 6.8, 100 mM -mercaptoethanol, 2% SDS) at 55 °C for 30 min and
then washed with TSBT. The goat polyclonal SP3 antibody (Santa Cruz) was incubated at a final dilution of 1/300, and the rabbit polyclonal actin antibody was incubated at a final dilution of 1/100. Appropriate anti-goat or anti-rabbit secondary antibodies were used as described above.
Statistics--
Numerical data are expressed as means ± S.E., and p values were determined by Student's
t test using Macintosh InStat 2.00 software (GraphPad, La
Jolla, CA).
 |
RESULTS |
Nuclear Run-on Assays--
Our previous studies demonstrated that
hyperoxia increased Na,K-ATPase 1 subunit mRNA
levels 5-fold in MDCK cells without a change in mRNA stability (9).
To demonstrate that hyperoxia increased Na,K-ATPase transcription, we
performed nuclear run-on assays in nuclei isolated from MDCK cells
treated with either normoxia or 12 h of hyperoxia. Nuclei were
incubated with nucleotides and 0.5 mCi of [32P]UTP, then
the newly synthesized RNA was hybridized to slot blots containing
Na,K-ATPase 1 subunit and pGEM (control) cDNAs.
There was no MDCK RNA nonspecific binding to the pGEM cDNA, whereas hyperoxia increased transcription of the Na,K-ATPase 1
gene 3.0-fold (Fig. 2).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
Nuclear run-on assays of MDCK cells in
normoxia and hyperoxia. Slot blots consisted of the following
cDNAs (10 µg/slot): Na,K-ATPase 1 subunit, pGEM
(control). MDCK cells were incubated in normoxia or hyperoxia, and RNA
was isolated from nuclei after treatment with 0.5 mCi of
[32P]UTP. The blots were hybridized with 1 million counts
of RNA, then autoradiographed. This blot is representative of two
experiments. N, normoxia; H, hyperoxia.
|
|
Identification of a Hyperoxia-responsive Element in the Na,K-ATPase
Promoter--
In our previous studies we localized a 61-bp region,
between 102 and 41, on the Na,K-ATPase 1 promoter
that was necessary for induction by hyperoxia (9, 18). This region
contained multiple GC elements, but no consensus sequences for
transcription factors with known responsiveness to oxidizing
conditions, such as AP1, anti-oxidant responsive element, or NF B. To
further define the area involved in hyperoxia up-regulation, we
transfected MDCK cells with deletion constructs of the Na,K-ATPase
1 promoter between 102 and 41, designated
1-84, 1-62, and 1-55 (Fig. 1). These constructs were generated via PCR, subcloned into the luciferase expression vector (pXP1), and transfected into MDCK cells.
Transfected cells were treated with either 48 h of normoxia or
hyperoxia after transfection (95% O2/5% CO2)
under normobaric conditions, then lysed, and luciferase activity was
measured. There were positive regulatory elements between 102 and
62, demonstrated by a decrease in basal promoter activity to 86.2% for the 1-84 construct and 27.7% for the
1-62 construct relative to the 1-102
construct (Table I). Both the
1-84 and the 1-62 constructs demonstrated
a 2-fold induction in promoter activity in the presence of hyperoxia,
thereby localizing a region necessary for hyperoxia induction to a
21-bp region between 62 and 41.
The 21-bp region between 62 and 41, which contained the
hyperoxia-inducible element, had an SP1 consensus sequence (GGCGG) spanning from 59 to 55. To eliminate this putative site, a
construct was generated via PCR, which spanned from 55 to +151 of the
Na,K-ATPase 1 promoter and was subcloned into the pXP1
luciferase expression vector (designated 1-55).
Transfection with the 1-55 construct in MDCK cells
demonstrated a marked decrease in basal promoter activity with only
10.5% promoter activity compared with the 1-62 construct (Fig. 3). In addition, deletion
of this GC element eliminated hyperoxia induction. Therefore, a GC
element between 62 to 55 contained a positive regulatory site for
induction by hyperoxia as well as basal promoter activity.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of hyperoxia on Na,K-ATPase
1 promoter activity. MDCK cell
transfection: Cells were transfected with either the
1-62 or 1-55 construct and exposed to
either normoxia or hyperoxia for 48 h. Cells were lysed, and
luciferase activity was measured. Data were normalized to protein
concentration. Data are reported as -fold increase over control,
i.e. Na,K-ATPase promoter activity in normoxia. Each data
point represents a mean ± S.E. of values from four different
experiments. *p 0.05 compared with normoxic
condition.
|
|
To determine whether hyperoxia could up-regulate this element
independent of the Na,K-ATPase promoter, we subcloned a dimer of an
oligonucleotide that contained the hyperoxia element and spanned from
82 to 44 into a plasmid containing luciferase and a minimal
promoter region from the MMTV gene. The empty MMTV plasmid had very low
basal promoter activity in MDCK cells and did not up-regulate with
hyperoxia (data not shown). In the presence of hyperoxia, the
82/ 44-MMTV construct was induced 5.1-fold (Fig. 4). Because this oligonucleotide
contained two GC elements ( 68/ 64 and 59/ 55), we eliminated the
distal 68 GC site by mutation. A similar construct containing a
multimer of the 82 to 44 oligonucleotide with a mutation of the GC
site at 68 to 64 was also inducible by hyperoxia, 4.1-fold (Fig.
4). This confirms that the GC site at 59 is sufficient for hyperoxia
induction of transcription.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
Induction by hyperoxia in a minimal promoter
construct. MDCK cells were transfected with either the
MMTV-82/44WT or MMTV-82/44SM constructs and exposed to either normoxia
or hyperoxia for 48 h. Transfection with the empty MMTV vector
showed low promoter activity and no induction by hyperoxia. Cells were
lysed, and luciferase activity was measured. Data were normalized to
protein concentration. Data are reported as -fold increase over
control, i.e. Na,K-ATPase promoter activity in normoxia.
Each data point represents a mean ± S.E. of values from five
different experiments.
|
|
The proximal promoter of the Na,K-ATPase 1 subunit
contained three separate GC boxes between 102 and 41 (Fig.
5A). We have demonstrated, in
our transfection experiments with serial deletions, that the GC element
at 59 is sufficient to induce the up-regulation by hyperoxia. To
determine whether the distal GC site ( 102 to 98) could up-regulate
Na,K-ATPase 1 promoter activity, we mutated the proximal
GC sites at 68 and 59 using site-directed mutagenesis of the
1-102 construct. Mutation of these two proximal GC sites resulted in a marked decrease in basal promoter activity to 24.1 + 11.6% of the wild type activity. However, induction by hyperoxia (1.9-fold) was maintained in the mutant 1-102 construct
( 1-102DM), identical to the wild type promoter construct
( 1-102WT; Fig. 5B). Therefore, the GC element
at 102 to 98 also was capable of up-regulating transcription in the
presence of hyperoxia.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5.
Induction by hyperoxia by the GC site at
102. A, GC sites in the proximal Na,K-ATPase
1 promoter. B, transfection experiments of
MDCK cells with either the 1-102 or
1-102DM constructs, which were exposed to either
normoxia or hyperoxia for 48 h. Cells were lysed, and luciferase
activity was measured. Data were normalized to protein concentration.
Data are reported as -fold increase over control, i.e.
Na,K-ATPase promoter activity in normoxia. Each data point represents a
mean ± S.E. of values from three different experiments.
|
|
Electrophoretic Mobility Shift Assays--
The transfection
experiments with the deletion constructs revealed a GC box, consistent
with a SP family consensus site, that was necessary for hyperoxia
induction. We performed EMSA to determine whether there was specific
protein-DNA binding correlating to this particular GC box. To determine
whether hyperoxia altered protein binding, EMSA of a double-stranded
oligonucleotide spanning the putative hyperoxia site ( 82 to 44) was
performed using nuclear extract (NE) from MDCK cells treated with
12 h of normoxia or hyperoxia. Using NE, we observed only a slight
increase in binding (1.3- to 1.5-fold, data not shown). Because
oxidation of nuclear binding proteins may be playing a role in the
regulation by hyperoxia, but could be masked by redox changes during
their extraction, we decreased the DTT concentration to see if this
reducing agent altered binding. In the absence of the reducing agent,
DTT, we were unable to isolate NE due to significant protein
precipitation. We were able to obtain whole cell extracts (WCE) in the
presence of very low levels of reducing agents, and the binding pattern was identical for NE and WCE (Fig.
6A). Electrophoretic mobility shift assays of a double-stranded oligonucleotide spanning the putative
hyperoxia site ( 82 to 44) incubated with WCE from MDCK cells in
normoxia conditions demonstrated binding of three bands (Fig.
6B). Two of the bands, designated A and B, represented
specific binding, because competition with excess cold oligonucleotide resulted in decreased binding (Fig. 6C). The third band, C,
represented nonspecific binding, because the binding pattern did not
change with excess cold probe.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 6.
Mobility shift assays of MDCK whole cell
extracts demonstrate increased binding in cells treated with hyperoxia
or diamide. A double-stranded DNA probe, which spanned from 82
to 44 (sequence is under "Materials and Methods") of the
1 Na,K-ATPase promoter was radiolabeled with
32P, incubated with extracts, and electrophoresed on a 4%
polyacrylamide gel as described under "Materials and Methods."
A, MDCK cells were incubated under normoxic conditions and
either whole cell extracts (WCE) or nuclear extracts
(NE) were obtained as described under "Materials and
Methods." Reactions contained 6.6 µg of extract and 0.3 ng of
probe. B, MDCK cells were incubated for 24 h in 1)
normoxia (N), 2) hyperoxia (H), or 3) diamide
(D), and WCE were obtained as described under "Materials
and Methods." Reactions contained 8.0 µg of extract and 0.2 ng of
probe. Arrows A and B represent specific
DNA-protein binding, arrow C represents nonspecific binding,
and arrow D represents excess free probe. In cells exposed
to hyperoxia or diamide, there was increased binding of bands A and B. The data are representative of three different experiments.
C, competition experiments with excess cold probe,
30X = 30-fold molar excess and 55X = 55-fold molar excess. Reactions contained 8.0 µg of extract and 0.2 ng of probe. Bands A and B were eliminated by competition with excess
probe, whereas there was no competition with band C. N,
extracts under normoxic conditions. D, quantitative scanning
densitometry of bands A and B from gel 6B. Each data point represents
the mean ± S.E. of values from three separate experiments and is
the ratio of the integrated optical density (IOD) of the
signal to that of control cells (normoxia). *p < 0.05, **p < 0.005 compared with normoxic control.
|
|
In extracts from cells treated with hyperoxia (Fig. 6, B and
D), we now demonstrated increased binding of bands A and B,
2.6- and 2.3-fold. In addition, we treated cells with 0.2 mM diamide, a thiol oxidizer, for 12 h in normoxic
conditions to determine if thiol-disulfide oxidation influenced protein
binding. WCE were collected for EMSA, which demonstrated increased
binding of both bands, A and B, in extracts from diamide-treated cells.
This effect was identical to the increased binding seen with hyperoxia
(Fig. 6, B and D). Therefore, treatment with the
thiol oxidizer, diamide, resulted in increased protein binding
identical to that seen in hyperoxia.
To identify the binding proteins, we performed competition experiments
in our EMSA by incubating the radiolabeled oligonucleotides with WCE
and excess cold probe containing an SP1 or an AP1 consensus site. The
oligonucleotide containing the SP1 consensus site binds members of the
SP1 family and competed with our radiolabeled probe which spanned the
putative hyperoxia site (Fig.
7A). This is consistent with
SP1 binding to our hyperoxia site. This competition was specific, because an oligonucleotide containing an AP1 consensus site did not
compete with our DNA probe containing the putative hyperoxia site (Fig.
7A).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Binding of SP proteins to the
Na,K-ATPase 1 proximal
promoter. WCE were obtained from MDCK cells maintained in normoxia
for 24 h as described under "Materials and Methods." A
double-stranded DNA probe, which spanned from 82 to 44 (sequence
under "Materials and Methods") was radiolabeled with
32P, incubated with WCE, and electrophoresed on a 6%
polyacrylamide gel. N = extracts under normoxic
conditions. A, competition experiments consisted of the
radiolabeled DNA probe incubated with WCE and excess (5-fold molar
excess = 5x and 10-fold molar excess = 10x) cold double-stranded DNA oligonucleotides containing:
oligo ( 82 to 44 sequence), AP1 (AP1 consensus sequence), or SP1
(SP1 consensus sequence). Reactions contained 6.5 µg of extract and
0.7 ng of probe. B, supershift experiments consisted of
incubating WCE with antibodies to SP1 and/or SP3. Reactions contained
6.6 µg of extract and 0.3 ng of probe. Arrows to the right
indicate positions of SP1- and SP3-specific complexes and their
respective antibody complexed supershifts. The data are representative
of four different experiments. NS, nonspecific protein
binding.
|
|
To confirm that SP1 binds to the hyperoxia regulatory region, we
performed EMSA in the presence of SP family antibodies to demonstrate
supershifting (Fig. 7B). Because a number of SP family members can bind to the GC consensus sequence, we performed EMSA with
both SP1 and SP3 antibodies. An oligonucleotide containing the
hyperoxia-responsive element ( 82 to 44) was incubated with WCE from
MDCK cells treated with hyperoxia and SP-specific antibodies. Supershift assays demonstrated that SP1 antibodies supershifted both
bands A and B, whereas, SP3 antibody supershifted only band A. Therefore, band A contained SP1- and SP3-specific proteins binding to
the GC consensus site. When the oligonucleotide was incubated with both
SP1 and SP3 antibodies, both bands A and B supershifted. These data, in
combination with the competition experiments, demonstrated that SP1 and
SP3 bind to the hyperoxia element that contains a GC consensus sequence.
The transfection experiments demonstrated a 7-bp region ( 62 to 55)
sufficient for hyperoxia induction, which contained a GC element
consistent with a SP1 consensus site. Competition and supershift assays
demonstrated SP1 and SP3 binding. The sequence between 102 to 55
contained three GC elements consistent with SP family consensus
sequences. These occur at 102 to 98, 68 to 64, and 59 to
55. Sequential deletion of the GC sites demonstrated that the GC site
at 59 was sufficient for hyperoxia induction. However, the distal
site, 102 to 98, was capable of induction by hyperoxia when the
proximal sites, 68 and 59, were eliminated by site-directed
mutagenesis. To identify which sites had higher affinity for the SP
proteins we performed a series of competition EMSA. In EMSA using the
82 to 44 probe, competition assays demonstrated strong competition
with cold oligonucleotides containing the GC site at 59 ( 66/ 44
and 82/ 44 oligonucleotides; Fig.
8A). In contrast, competition
assays with an oligonucleotide ( 86/ 62) containing only the GC site
at the 68 position demonstrated weak competition (Fig.
8A). Although we have not ruled out some contribution of the
GC site at 68, the GC element at 59 was sufficient for hyperoxia
induction, and the SP proteins have a higher binding affinity for this
site.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 8.
Competition of hyperoxia element with other
GC elements. WCE were obtained from MDCK cells maintained in
normoxia for 24 h as described under "Materials and Methods."
N, extracts under normoxic conditions. A, a
double-stranded DNA probe, which spanned from 82 to 44 (sequence
under "Materials and Methods") was radiolabeled with
32P, incubated with WCE (6.6 µg), and electrophoresed on
a 6% polyacrylamide gel. Competition experiments consisted of the
radiolabeled DNA probe incubated with WCE and excess (30-fold molar
excess) cold double-stranded DNA oligonucleotides containing: 82 to
44 sequence, 86 to 62 sequence, or a 66 to 44 sequence.
Oligonucleotides containing the 59 to 55 GC site demonstrated
greater competition. B, a double-stranded DNA probe, which
spanned from 82 to 44 (sequence under "Materials and Methods")
was radiolabeled and electrophoresed as described above. The probe
contained either a single mutation (SM) at the 68 GC site
or a double mutation (DM) at the 68 and 59 GC sites (see "Materials and Methods"). Competition
experiments consisted of the radiolabeled DNA probe incubated with WCE
and excess (30-fold molar excess) cold double-stranded DNA
oligonucleotides: SM, DM, or wild type (WT). Reactions
contained 7.5 µg of extract and 0.3 ng of probe. C, a
double-stranded DNA probe, which spanned from either 122 to 84 or
82 to 44 (sequence under "Materials and Methods") was
radiolabeled and electrophoresed as described above. Reactions
contained 6.3 µg of extract and 0.3 ng of probe. Competition
experiments consisted of the radiolabeled DNA probe incubated with WCE
and excess (30-fold molar excess) cold double-stranded DNA
oligonucleotide as described previously. NS, nonspecific
protein binding.
|
|
In EMSA using an oligonucleotide containing a probe ( 82 to 44) with
a single mutation (SM) of the GC element located at 68 and preserved
59 GC box, protein binding was identical to that seen with the wild
type oligonucleotide (Fig. 8B). Whereas, all SP1 and SP3
protein binding was eliminated with an oligonucleotide containing a
double mutation (DM) of both GC sites ( 68 and 59), demonstrating
that mutation of the 59 site was necessary to eliminate SP1 and SP3
binding (Fig. 8B). In EMSA with the SM probe, competition assays demonstrated competition with excess cold SM and wild type oligonucleotides, both which contain the intact 59 GC box. There was
no competition with excess cold DM oligonucleotides, which contained
the mutated 59 GC site. This confirmed that the GC element at 59 is
sufficient for hyperoxia-induced promoter activity and SP protein
binding, whereas the GC site at 68 is a weak competitor for SP family
member binding and is not necessary for hyperoxia induction.
Next, we sought to determine the role of the GC box at 102.
Transfection experiments with site-directed mutagenesis revealed that
the GC site at 102 was capable of induction by hyperoxia. To
determine the binding pattern of this GC site, we performed EMSA using
an oligonucleotide, which spanned this element ( 122/ 84). EMSA
demonstrated a similar binding pattern to the oligonucleotides that
contained the GC site at 59 (Fig. 8C). In addition,
competition assays of the 122/ 84 probe demonstrated competition
with the 82/ 44 and the SP1 oligonucleotides, but not with an AP1
oligonucleotide. The 82/ 44 oligonucleotide, which contained the
59 GC site, was a very strong competitor of the 122/ 84 probe. In
contrast, the oligonucleotide containing the GC site at 102
( 122/ 84 oligonucleotide) was a weak competitor for the GC binding
site on the 82/ 44 probe. Thus, the Na,K-ATPase 1
proximal promoter contained three GC sites, and we have demonstrated
that either of two sites ( 102 or 59) are capable of induction by
hyperoxia, however, the GC site at 59 has the highest binding
affinity for SP family members and is sufficient for induction by hyperoxia.
Protein Expression of SP1 and SP3--
The mechanism by which
hyperoxia increased SP family member binding to the Na,K-ATPase
1 gene remains unknown. Increased SP binding can be due
to increased protein affinity or increased available protein. The
latter can be due to either transcriptional or post-transcriptional
regulation of SP family members. To determine whether increased
available SP1 or SP3 protein was present with hyperoxia, we performed a
Western blot on whole cell extract from cells treated with normoxia or
hyperoxia (Fig. 9). Protein levels of SP1
or SP3 remained constant in the presence of hyperoxia. This suggested
that increased SP binding was due to increased affinity and not due to
an increase in available protein.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 9.
Expression of SP1 and SP3 from MDCK cells in
normoxia and hyperoxia. A representative Western blot of WCE
collected from cells treated in normoxia (N) or hyperoxia
(H). C, protein control lane obtained from the manufacturer
of the antibody. Approximately 10 µg of protein/lane was resolved on
an 8% polyacrylamide gel and transferred to a nitrocellulose membrane
before immunoblotting with polyclonal antibodies to SP1, SP3, or actin
according to "Materials and Methods." No differences in protein
concentrations were seen in treated or untreated cells.
|
|
 |
DISCUSSION |
The Na,K-ATPase is an important protein for maintaining normal
cellular function. This is emphasized by its presence in all cells and
high levels in cells specialized in sodium transport (1-3). The sodium
pump consists of two subunits, and , which are necessary for
normal enzyme activity. In some tissues, such as the lung,
overexpression or up-regulation of the subunit results in increased
activity, whereas, this is not true for the subunit (5, 6). This
implies that the subunit is the rate-limiting subunit.
There are many factors that influence Na,K-ATPase regulation, including
oxidant stress. Up-regulation of the Na,K-ATPase gene expression by
hyperoxia has been previously described in both lung and kidney
epithelia (5, 9, 10-12). In the lung, hyperoxia up-regulates
Na,K-ATPase gene expression 2- to 6-fold with a concomitant increase in
enzyme activity that is dependent on the duration and type of hyperoxia
exposure (5, 9, 10-12). In addition, there is evidence that the
up-regulation of pump expression by hyperoxia in MDCK cells increased
ion transport as demonstrated by the formation of domes in
vitro (13). However, the molecular mechanism by which hyperoxia
influenced Na,K-ATPase gene expression and enzyme activity remained unknown.
Using MDCK cells exposed to hyperoxia as a model system, we now
demonstrate that hyperoxia increased Na,K-ATPase 1 gene
expression via an increase in transcription. To define the element
necessary for hyperoxia induction of the Na,K-ATPase 1
gene, we performed transfection experiments using sequential deletions
of the Na,K-ATPase 1 promoter between 102 and 41.
These transfection experiments revealed a GC box between 59 to 55
that was necessary for basal promoter activity and sufficient for
induction by hyperoxia. Two other GC sites, which were homologous for
SP1 sites, also exist in this region between 102 and 68. Sequential
deletions of these elements resulted in partial loss of basal promoter
activity, however, the two-fold induction by hyperoxia was preserved.
Mutations of the 68 and 59 GC sites within the wild type promoter
revealed that the intact 102 GC site, in the absence of the 68 and
59 site, was functional and could be induced by hyperoxia. These data
suggested that the 59 GC site is sufficient for hyperoxia induction,
however, other GC sites are functional. In addition, there may be
additional regulatory sites outside of our cloned promoter, because
hyperoxia increased Na,K-ATPase 1 mRNA 5-fold and we
identified only a 2-fold induction in promoter activity.
EMSA of oligonucleotides containing the 59 GC site demonstrated that
hyperoxia increased binding of two bands that contained SP1 and SP3 as
demonstrated by supershift and competition assays. Competition assays
revealed that the 68 and 102 sites were weak competitors for SP1
and SP3 binding compared with the 59 site, suggesting the 59 site
had higher affinity for SP1 and SP3. The EMSA demonstrated increased
binding in the band containing SP1 alone and the band containing both
SP1 and SP3. Therefore, it is unknown whether SP1 protein binding
increased solely, or whether there was a concomitant increase in SP3
binding as well. In many systems, SP1 activates transcription, such as
the Na,K-ATPase 3 subunit gene (19). The role of SP3 in
gene regulation varies between different promoters and cell types. SP3
represses SP1 transcriptional activation of the human thrombin receptor
and uteroglobin gene (20), whereas, it up-regulates SP1 transcriptional regulation in the hepatic growth factor promoter (21). There are
two possibilities in our system. First, SP1 and SP3 may be acting
synergistically to activate Na,K-ATPase 1 transcription and hyperoxia might increase the binding of both factors.
Alternatively, SP3 may be playing an inhibitory role and hyperoxia
might lead to increased SP1 binding and an increased SP1/SP3 ratio with
subsequent increased transcription.
SP1 and SP3 belong to a transcription factor family that contain three
zinc finger motifs. Promoter elements containing the core sequence
GGG(C/T/A)GG bind several transcription factors, including
members of the SP family (22). The SP transcription factor family
members bind with different affinities to these DNA sites. This binding
specificity is cell-specific, promoter-specific, and varies according
to the consensus sequence (23, 24). These transcription factors are
ubiquitous in mammalian cells and contain several different isoforms,
all which bind to the core sequence and vary in abundance (20, 25, 26).
SP1 plays a critical role in promoters without TATA or CAAT consensus
sequences, however, SP1 also is functional in genes with TATA boxes
(27, 28). The Na,K-ATPase 1 promoter contains a TATA box
at 31, however, its function has not been demonstrated. SP1 has been
described as a positive regulator of transcription, whereas, SP3 has
been shown to either activate or repress transcription in different cell types (22, 29-33). The role of SP3 is promoter and cell type-specific, and the ratio of SP1 to SP3 may be important in transcriptional regulation.
The SP family members are usually associated with basal promoter
activity, however, they contain zinc finger sulfhydryl groups that are
sensitive to oxidation and direct redox changes alter SP regulated
transcription (34, 35). Wu et al. (35) demonstrated that
oxidizing conditions led to a decrease in SP1 binding and promoter
activity in HeLa cells. This occurred in extracts from cells treated
with oxidizing agents and extracts treated directly. In our system,
hyperoxia and the oxidizing agent diamide led to increased DNA binding.
Hyperoxia is felt to be toxic to cells due to oxidant injury, and this
may be the mechanism of gene induction. The amount of injury by
hyperoxia varies between different cells, and, in MDCK cells, it has
been demonstrated that hyperoxia decreases proliferation in
subconfluent cells, whereas, cellular death remains unchanged (36).
Diamide is an agent that oxidizes sulfhydryl groups; therefore, thiol
oxidation may be a mechanism by which hyperoxia induced Na,K-ATPase
1subunit promoter activity. These redox changes may
affect SP3 and/or SP1 binding capacity directly or indirectly.
Alternatively, we sought to determine if hyperoxia directly influenced
SP1 or SP3 expression. Hypoxia up-regulated -enolase and pyruvate
kinase-M promoters by down-regulating the expression of the inhibitory
factor, SP3, thereby increasing the SP1/SP3 ratio (37). In our system,
hyperoxia did not change protein levels of either SP1 or SP3 suggesting
altered binding affinity was responsible for increased binding on
EMSA.
In summary, we demonstrate that hyperoxia increased Na,K-ATPase
1 transcription via a GC element in its proximal
promoter. Multiple GC boxes exist in the Na,K-ATPase 1
proximal promoter, at least two of which are capable of up-regulating
transcription in the presence of hyperoxia. These sites bind the SP
family members SP1 and SP3, which increase in binding in the presence
of hyperoxia. These transcription factors are necessary for both basal
and hyperoxia-induced regulation of the Na,K-ATPase 1
promoter, and this represents a novel oxidant
stress-dependent regulation by SP1/SP3 transcription factors.
 |
FOOTNOTES |
*
Some of the results contained in Table I were published in
abstract form as a supplement to Chest 116, 87S-88S (Aspen
Lung Conference, 1998).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: University of
Minnesota, Dept. of Medicine, Box 276 Mayo Mail Code, 420 Delaware St. SE, Minneapolis, MN 55455. Tel.: 612-624-0999; Fax:
612-625-2174; E-mail: wendt005@tc.umn.edu.
Published, JBC Papers in Press, September 14, 2000, DOI 10.1074/jbc.M004759200
 |
ABBREVIATIONS |
The abbreviations used are:
MDCK, Madin-Darby
canine kidney;
EMSA, electrophoretic mobility shift assay;
bp, base pair(s);
FBS, fetal bovine serum;
PCR, polymerase chain reaction;
MMTV, mouse mammary tumor virus;
PMSF, phenylmethylsulfonyl fluoride;
DTT, dithiothreitol;
WCE, whole cell extract;
NE, nuclear extract;
SM, single mutation;
DM, double mutation.
 |
REFERENCES |
| 1.
|
Horisberger, J.,
Lemas, V.,
Kraehenbuhl, J. P.,
and Rossier, B. C.
(1991)
Annu. Rev. Physiol.
53,
565-584
|
| 2.
|
Skou, J. C.
(1988)
Methods Enzymol.
156,
1-25
|
| 3.
|
Geering, K.
(1991)
FEBS Lett.
285,
189-193
|
| 4.
|
Factor, F.,
Saldias, F.,
Ridge, K.,
dumasius, V.,
Zabner, J.,
Jaffe, H. A.,
Blanco, G.,
Barnard, M.,
Mercer, R.,
Perrin, R.,
and Sznajder, J. I.
(1998)
J. Clin. Invest.
102,
1421-1430
|
| 5.
|
Carter, E. P.,
Wangensteen, O. D.,
O'Grady, S. M.,
and Ingbar, D. H.
(1997)
Am. J. Physiol.
272,
L542-L551
|
| 6.
|
Chalaka, S.,
Ingbar, D. H.,
Sharma, R.,
Zhau, Z.,
and Wendt, C. H.
(1999)
Am. J. Physiol.
277,
L197-L203
|
| 7.
|
Lingrel, J. B.,
Orlowski, J.,
Shull, M. M.,
and Price, E. M.
(1990)
Prog. Nucleic Acids Res.
38,
37-89
|
| 8.
|
Liu, B.,
Huang, F.,
and Gick, G.
(1993)
Cell. Mol. Biol. Res.
39,
221-229
|
| 9.
|
Wendt, C.,
Towle, T.,
Sharma, R.,
Duvick, S.,
Kawakami, K.,
Gick, G.,
and Ingbar, D. H.
(1998)
Am. J. Physiol.
274,
C356-C364
|
| 10.
|
Harris, Z. L.,
Ridge, K. M.,
Gonzalez-Flecha, B.,
Gottlieb, L.,
Zucker, A.,
and Sznajder, J. I.
(1996)
Eur. Respir. J.
9,
472-477
|
| 11.
|
Olivera, W.,
Ridge, K.,
Wood, L. D. H.,
and Sznajder, J. I.
(1994)
Am. J. Physiol.
266,
L577-L584
|
| 12.
|
Nici, L.,
Dowin, R.,
Gilmore-Hebert, M.,
Jamieson, J. D.,
and Ingbar, D. H.
(1994)
Am. J. Physiol.
261,
L307-L314
|
| 13.
|
Dreher, D.,
and Tochat, T.
(1992)
Am. J. Physiol.
262,
C358-C364
|
| 14.
|
Rushmore, T. H.,
Morton, M. R.,
and Pickett, C. B.
(1991)
J. Biol. Chem.
266,
11632-11639
|
| 15.
|
Pinkus, R.,
Weiner, L. M.,
and Daniel, V.
(1996)
J. Biol. Chem.
271,
13422-13429
|
| 16.
|
Meyer, M.,
Pahl, H. L.,
and Baeuerle, P. A.
(1994)
Chem.-Biol. Interact.
91,
91-100
|
| 17.
|
Liu, B.,
and Gick, G.
(1992)
Biochim. Biophys. Acta
1130,
336-338
|
| 18.
|
Wendt, C.,
Sharma, R.,
Towle, T.,
Gick, G.,
and Ingbar, D. H.
(1999)
Chest
116,
87S-88S
|
| 19.
|
Murakami, Y.,
Ikeda, U.,
Shimada, K.,
and Kawakami, K
(1997)
Biochim. Biophys. Acta
1352,
311-324
|
| 20.
|
Wu, Y.,
Ruef, J.,
Rao, G. N.,
Patterson, C.,
and Runge, M. S.
(1998)
Biochem. J.
330,
1469-1474
|
| 21.
|
Jiang, J.-G.,
Chen, Q.,
Bell, A.,
and Zarnegar, R.
(1997)
Oncogene
14,
3039-3049
|
| 22.
|
Marin, M.,
Karis, A.,
Visser, P.,
Grosveld, F.,
and Philipsen, S.
(1997)
Cell
89,
619-628
|
| 23.
|
Hata, Y.,
Duh, E.,
Zhang, K.,
Robinson, G. S.,
and Aiello, L. P.
(1998)
J. Biol. Chem.
273,
19294-19303
|
| 24.
|
Netzker, R.,
Weigert, C.,
and Brand, K.
(1997)
Eur. J. Biochem.
245,
174-181
|
| 25.
|
Dennig, J.,
Beato, M.,
and Suske, G.
(1996)
EMBO J.
15,
5659-5667
|
| 26.
|
Hagen, G.,
Dennig, J.,
Preiss, A.,
Beato, M.,
and Suske, G.
(1995)
J. Biol. Chem.
270,
24989-24994
|
| 27.
|
Chu, S.,
Blaisdell, C. J.,
Lui, M.-Z. M.,
and Zeitlin, P. L.
(1999)
Am. J. Physiol.
276,
L614-L624
|
| 28.
|
Toonen, R. F. G.,
Gowan, S.,
and Bingle, C. D.
(1996)
Biochem. J.
316,
467-473
|
| 29.
|
Hagen, G.,
Müller, S.,
Beato, M.,
and Suske, G.
(1994)
EMBO J.
13,
3843-3851
|
| 30.
|
Birnbaum, M. J.,
van Wijnen, A. J.,
Odgren, P. R.,
Last, T. J,
Suske, G.,
Stein, G. S.,
and Stein, J. L.
(1995)
Biochem.
34,
16503-16508
|
| 31.
|
Kumar, A. P.,
and Butler, A. P.
(1997)
Nucleic Acids Res.
25,
2012-2019
|
| 32.
|
Rajakumar, R. A.,
Thamotharan, S.,
Menon, R. K.,
and Devaskar, S. U.
(1998)
J. Biol. Chem.
273,
27474-27483
|
| 33.
|
Schanke, J. T.,
Durning, M.,
Johnson, K. J.,
Bennett, L. K.,
and Golos, T. G.
(1998)
Mol. Endocrinol.
12,
405-417
|
| 34.
|
Wu, X.,
Bishopric, N. H.,
Discher, D. J.,
Murphy, B. J.,
and Webster, K. A.
(1996)
Mol. Cell. Biol.
16,
1035-1046
|
| 35.
|
Hamm-Künselmann, B.,
Schäfer, D.,
Weigert, C.,
and Brand, K.
(1997)
FEBS Lett.
403,
87-90
|
| 36.
|
Jyonouchi, H.,
Sining, S.,
Mizokami, M.,
and Ingbar, D. H.
(1997)
Nutr. Cancer
28,
115-124
|
| 37.
|
Discher, D. J.,
Bishopric, N. H.,
Wu, S.,
Peterson, C. A.,
and Webster, K. A.
(1998)
J. Biol. Chem.
273,
26087-26093
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Matlhagela and M. Taub
Regulation of the Na-K-ATPase beta1-subunit promoter by multiple prostaglandin-responsive elements
Am J Physiol Renal Physiol,
September 1, 2006;
291(3):
F635 - F646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Barre, N. Venkatesan, J. Magdalou, P. Netter, S. Fournel-Gigleux, and M. Ouzzine
Evidence of calcium-dependent pathway in the regulation of human {beta}1,3-glucuronosyltransferase-1 (GlcAT-I) gene expression: a key enzyme in proteoglycan synthesis
FASEB J,
August 1, 2006;
20(10):
1692 - 1694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Azakie, J. R. Fineman, and Y. He
Sp3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivo
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H600 - H611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Matlhagela, M. Borsick, T. Rajkhowa, and M. Taub
Identification of a Prostaglandin-responsive Element in the Na,K-ATPase {beta}1 Promoter That Is Regulated by cAMP and Ca2+: EVIDENCE FOR AN INTERACTIVE ROLE OF cAMP REGULATORY ELEMENT-BINDING PROTEIN AND Sp1
J. Biol. Chem.,
January 7, 2005;
280(1):
334 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hao, C. H. Wendt, G. Sandhu, and D. H. Ingbar
Dexamethasone stimulates transcription of the Na+-K+-ATPase {beta}1 gene in adult rat lung epithelial cells
Am J Physiol Lung Cell Mol Physiol,
September 1, 2003;
285(3):
L593 - L601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhou, W. Yin, S. Q. Doi, S. W. Robinson, K. Takeyasu, and X. Fan
Stimulation of Na,K-ATPase by low potassium requires reactive oxygen species
Am J Physiol Cell Physiol,
August 1, 2003;
285(2):
C319 - C326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Sznajder, P. Factor, and D. H. Ingbar
Lung Edema Clearance: 20 Years of Progress: Invited Review: Lung edema clearance: role of Na+-K+-ATPase
J Appl Physiol,
November 1, 2002;
93(5):
1860 - 1866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Cho, A. E. Jedlicka, S. P. M. Reddy, L.-Y. Zhang, T. W. Kensler, and S. R. Kleeberger
Linkage Analysis of Susceptibility to Hyperoxia . Nrf2 Is a Candidate Gene
Am. J. Respir. Cell Mol. Biol.,
January 1, 2002;
26(1):
42 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Bremner, T. Freywald, H. M. O'Brodovich, and G. Otulakowski
Promoter analysis of the gene encoding the beta -subunit of the rat amiloride-sensitive epithelial sodium channel
Am J Physiol Lung Cell Mol Physiol,
January 1, 2002;
282(1):
L124 - L134.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|